NEWS

Alvimedica launches the new Alvision™ KAPLAN curves radial portfolio for diagnostic procedures

Alvimedica started a new research program sponsored by Piedmont Region

Cre8™ EVO provides superior results in DM patients

10 years of Cre8™ legacy

Alvimedica Announces the CE Mark approval of the new polymer free self expanding Amphilimus eluting DES for SFA lesions, NiTiDES™

Alvimedica @ the EuroPCR 2021: “Empowering DES performance in complex patients to maximise efficacy and safety outcomes"

Alvimedica announces the CE Mark approval of its new, first and unique Non compliant balloon - Fluydo ™ NC.

Alvimedica @ JIM 2021: “The latest updates of ReCre8 all-comers RCT with short DAPT”

Alvimedica @ LINC 2021: “ILLUMINA Study 2 years results: latest updates”

Alvimedica at the e-Euro PCR 2020: “Latest insights from the ReCre8 randomized trial"

Alvimedica at Linc 2020

ILLUMINA study 2 years results stand NiTiDES at the top of excellence in today SFA DES scenario

Alvimedica announces the approval for its Cre8™ & Cre8™ EVO DES to be implanted with just 1month DAPT duration when clinically indicated.

EuroPCR2019: Alvimedica post session wrap-up interview

CE mark of Cre8™ EVO 2.0mm

ReCre8: A randomized trial evaluating a polymer-free coronary drug-eluting stent in an all-comers patient population

Diab8: The randomized clinical trial comparing the polymer-free Amphilimus™ eluting stent to the Everolimus eluting stent in all-comer Diabetes Mellitus patients

The First and Only Diabetic DES Randomized Trial Designed for Superiority: DIAB8

Alvimedica to strengthen manufacturing footprint for the future

EuroPCR 2017 Wrap-Up Interview

Challenges in diabetic patients

First Cre8™ implants in New Zealand

Illumina study Enrolment is Complete

AsiaPCR Wrap up interview

Cre8™ EVO showcased at the JIM 2017

Cre8™ EVO Approval of CE Mark

ICI Meeting 2016

Cre8™ Launch in Australia and New Zealand

Alvimedica at TCT 2016

PCI in Diabetics: TNT Wrap up Interview

Interview with Alvimedica CEO at EuroPCR 2016

Alvimedica TNT session at EuroPCR 2016

Alvimedica at 23rd National Interventional Cardiology Meeting

Alvimedica at LINC

Alvimedica at Asia PCR

Alvimedica Launches Cre8™ 46mm

Endovascular portfolio

Alvimedica merger with CID